ANNEXSupplementary provisions
ANNEX The entry for lasalocid in Table 1 of the Annex to Regulation (EU) No 37/2010 is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Lasalocid Lasalocid A Poultry 20 μg/kg Muscle NO ENTRY Anti-infectious agents/Antibiotics’ 100 μg/kg Skin and fat 100 μg/kg Liver 50 μg/kg Kidney 150 μg/kg Eggs Bovine 10 μg/kg Muscle Not for use in animals from which milk is produced for human consumption 20 μg/kg Fat 100 μg/kg Liver 20 μg/kg Kidney